SEARCH

SEARCH BY CITATION

REFERENCES

  • Chiavegatto S, Sun J, Nelson RJ, Schnaar RL. 2000. A functional role for complex gangliosides: Motor deficits in GM2/GD2 synthase knockout mice. Exp Neurol 166:227234.
  • Doherty P, Dickson JG, Flanigan TP, Walsh FS. 1985. Ganglioside GM1 does not initiate, but enhances neurite regeration of nerve growth factor-dependent sensory neurones. J Neurochem 44:12591265.
  • Duchemin AM, Ren Q, Mo L, Neff NH, Hadjiconstantinou M. 2002. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J Neurochem 81:696707.
  • Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, Annane D, Gaillard JL, Lofaso F, Raphael JC, Sharshar T. 2006. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre syndrome: A prospective study. Lancet Neurol 5:10211028.
  • Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR. 2000. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:4151.
  • Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N, Furukawa K, Furukawa K, Plomp JJ, Willison HJ. 2005. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci 25:16201628.
  • Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ. 1999. Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 104:697708.
  • Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, Willison HJ. 2005a. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol 58:203210.
  • Halstead SK, Morrison I, O'Hanlon GM, Humphreys PD, Goodfellow JA, Plomp JJ, Willison HJ. 2005b. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia 52:177189.
  • Hamberger A, Svennerholm L. 1971. Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions. J Neurochem 18:18211829.
  • Hopkins WG, Liang J, Barrett EJ. 1986. Effect of age and muscle type on regeneration of neuromuscular synapses in mice. Brain Res 372:163166.
  • Itoh M, Fukumoto S, Iwamoto T, Mizuno A, Rokutanda A, Ishida HK, Kiso M, Furakawa K. 2001. Specificity of carbohydrate structures of gangliosides in the activity to regenerate the rat axotomized hypoglossal nerve. Glycobiology 11:125130.
  • Jacobs BC, O'Hanlon GM, Bullens RW, Veitch J, Plomp JJ, Willison HJ. 2003. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminal through inhibition of antibody binding. Brain 126:22202234.
  • Kawai H, Allende ML, Wada R, Kono M, Sango K, Deng C, Miyakawa T, Crawley JN, Werth N, Bierfreund U, Sandhoff K, Proia RL. 2001. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276:68856888.
  • Kittaka D, Itoh M, Ohmi Y, Kondo Y, Fukumoto S, Urano T, Tajima O, Furakawa K, Furakawa K. 2008. Impaired hypoglossal nerve regeneration in mutant mice lacking complex gangliosides: down-regulation of neurotrophic factors and receptors as possible mechanisms. Glycobiology 18:509516.
  • Lehmann HC, Lopez PH, Zhang G, Ngyuen T, Zhang J, Kieseier BC, Mori S, Sheikh KA. 2007. Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci 27:2734.
  • Liu Y, Wada R, Kawai H, Sango K, Deng C, Tai T, McDonald MP, Araujo K, Crawley JN, Bierfreund U, Sandhoff K, Suzuki K, Proia RL. 1999. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103:497505.
  • Love FM, Thompson WJ. 1998. Schwann cells proliferate at rat neuromuscular junctions during development and regeneration. J Neurosci 18:93769385.
  • McGonigal R, Rowan EG, Greenshields KN, Halstead SK, Humphreys PD, Rother RP, Furukawa K, Willison HJ. 2010. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 133:19441960.
  • O'Hanlon GM, Plomp JJ, Chakrabarti M, Morrison I, Wagner ER, Goodyear CS, Yin X, Trapp BD, Conner J, Molenaar PC, Stewart S, Rowan EG, Willison HJ. 2001. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124:893906.
  • Okada M, Itoh MM, Haraguchi M, Okajima T, Inoue M, Oishi H, Matsuda Y, Iwamoto T, Kawano T, Fukumoto S, Miyazaki H, Furukawa K, Aizawa S, Furukawa K. 2002. b-series ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277:16331636.
  • Olsson Y. 1968. Topographical differences in vascular permeability of peripheral nervous system. Acta Neuropathol 10:2633.
  • Pestronk A, Drachman DB, Griffin JW. 1980. Effects of aging on nerve sprouting and regeneration. Exp Neurol 70:6582.
  • Plomp JJ, Willison HJ. 2009. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol 587:39793999.
  • Rajabally Y, Uncini A. 2012. Outcome and its predictors in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 83:711718.
  • Reynolds ML, Woolf CJ. 1992. Terminal Schwann cells elaborate extensive processes following denervation of motor endplate. J Neurocytol 21:5066.
  • Robbins N, Kuchynski M, Polak J, Grasso A. 1990. Motor nerve terminal restoration after focal destruction in young and old mice. Int J Dev Neurosci 8:667678.
  • Rupp A, Morrison I, Barrie JA, Halstead SK, Townson KH, Greenshields KN, Willison HJ. 2012. Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: An in and ex vivo imaging study in the mouse. Exp Neurol 233:836848.
  • Santafe MM, Sabate MM, Garcia N, Ortiz N, Lanuza MA, Tomas J. 2005. Changes in the neuromuscular synapse induced by an antibody against gangliosides. Ann Neurol 57:396407.
  • Sheik KA, Zhang G, Gong Y, Schnaar RL, Griffin JW. 2004. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann Neurol 56:228239.
  • Son YJ, Thompson WJ. 1995. Schwann cell processes guide regeneration of peripheral axons. Neuron 14:125132.
  • Son YJ, Trachtenberg JT, Thompson WJ. 1996. Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions. Trends Neurosci 7:280285.
  • Sugiura Y, Furukawa K, Tajima O, Mii S, Honda T, Furukawa K. 2005. Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides. Neuroscience 135:11671178.
  • Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, Furukawa K, Furukawa K, Rasband MN, Yuki N. 2007. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55:746757.
  • Svennerholm L. 1963. Chromatographic separation of human brain gangliosides. J Neurochem 10:613623.
  • Takamiya K, Yamamoto A, Furukawa K, Yamashiro S, Shin M, Okada M, Fukumoto S, Haraguchi M, Takeda N, Fujimura K, Sakae M, Kishikawa M, Shiku H, Furukawa K, Aizawa S. 1996. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci USA 93:1066210667.
  • van Koningsveld R, Schmitz PI, Ang CW, Groen J, Osterhaus AD, Van der Meche FG, van Doorn PA. 2002. Infections and course of disease in mild forms of Guillain-Barre syndrome. Neurology 58:610614.
  • van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. 2007. A clinical prognostic scoring system for Guillain Barré syndrome. Lancet Neurol 6:589594.
  • Verdú E, Butí M, Navarro X. 1995. The effect of aging on efferent nerve fibers regeneration in mice. Brain Res 696:7682.
  • Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC. 2011. Early recognition of poor prognosis in Guillain-Barré syndrome. Neurology 76:968975.
  • Yu RK, Tsai YT, Ariga T, Yanagisawa M. 2011. Structures, biosynthesis, and functions of gangliosides—An overview. J Oleo Sci 60:537544.
  • Yuki N, Hartung HP. 2012. Guillain-Barré syndrome. N Engl J Med 366:22942304.
  • Zeller CB, Marchase RB. 1992. Gangliosides as modulators of cell function. Am J Physiol 262:C1341C1355.
  • Zitman FM, Todorov B, Jacobs BC, Verschuuren JJ, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. 2008. Neuromuscular synaptic function in mice lacking major subsets of gangliosides. Neuroscience 156:885897.
  • Zitman FM, Todorov B, Verschuuren JJ, Jacobs BC, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. 2011. Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiol Aging 32:157167.
  • Zuo Y, Lubischer JL, Kang H, Tian L, Mikesh M, Marks A, Scofield VL, Maika S, Newman C, Krieg P, Thompson WJ. 2004. Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination. J Neurosci 24:1099911009.